Pre-market summary on your portfolio: Delacrox

See the latest news & analysis on your portfolio...

Pre-market Portfolio Digest

* As of Thu, Jun 15, 2023 08:08 ET

Portfolio Health Check

Score Your rating score is 3.29 / 5.0	Breakdown Strong Buy: 2 stocks Buy: 3 stocks Hold: 18 stocks Sell: 4 stocks Strong Sell: 0 stocks

See full portfolio health check » 

Yesterday's Performance

Top Gainers

VTRS: +1.35%

PG: +0.94%

K: +0.85%

Top Losers

RTX: -2.84%

PFE: -2.28%

AA: -1.55%

Top Gainers	Top Losers
VTRS: +1.35%	RTX: -2.84%
PG: +0.94%	PFE: -2.28%
K: +0.85%	AA: -1.55%

See all of your holdings » 

Breaking News

	AbbVie files patent lawsuit over BeiGene's cancer drug - Bloomberg SA News • JNJ
	Gibson Energy to buy South Texas Gateway oil export terminal in $1.1B deal SA News • PSX
	Bristol-Myers Squibb Company  declares $0.57 dividend SA News • BMY
	afran said to near $1.8B purchase of Raytheon unit SA News • RTX
	Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada SA News • JNJ
	Albemarle, Linde, Eastman are top picks in new chemicals coverage at Citi SA News • DD • DOW

See all news on your portfolio »

FEATURED: Be a better investor with Premium

Research shows that individual investors collectively underperform the market, because their decisions are often driven by emotions. Stay ahead of the curve with Seeking Alpha Premium's in-depth analysis and data-driven stock ratings.

Go Premium now »

Analysis

	Procter & Gamble Is A Good Buy At Current Valuation GS Analytics • PG
	Coca-Cola Vs. PepsiCo: Which Is Better Positioned To Sell Puts? PropNotes • KO
	Johnson & Johnson (JNJ) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript) SA Transcripts • JNJ
	Viatris Inc. (VTRS) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript) SA Transcripts • VTRS
	Pfizer Inc. (PFE) Presents At Goldman Sachs 44th Annual Global Healthcare Conference Call Transcript SA Transcripts • PFE
	Pfizer: Deeper Value Found Amidst Diversified Pipelines WR Investment Group • PFE
	Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript) SA Transcripts • BMY
	There's No Reason AT&T Won't Pay Your Dividends Livy Investment Research • T
	Procter & Gamble: Financials Improved But The Valuation Is Not Attractive Dair Sansyzbayev • PG
	Procter & Gamble: Price Dependence Makes It Vulnerable To Recession (Rating Downgrade) Skeptical12 • PG
	Procter & Gamble: What This Correction Means For Investors Leo Nelissen • PG
	Procter & Gamble: Stable Prospects But Likely Baked In LD Investments • PG
	Hawaiian Electric: Surprisingly Good Stability, But Population Decline A Drag Power Hedge • HE
	Alcoa: Exploring The Mystery Of High Tax Rates Hong Chew Eu • AA
	2 Reasons To Sell 3M Stock Despite The 'Good' News Deep Value Ideas • MMM
	Dominion Energy: Too Much Management Uncertainty George Fisher • D
	Dow: A Blue Chip Now With A 9.7% FCF Yield Cameron Smith • DOW

See all analysis on your portfolio »

Related Analysis

	How AI Is Advancing The Energy Transition VanEck • CTVA
	Why The Fed Has Just One Core Problem After The Rate Skip Chris Lau • JNJ
	Axsome: NDA Resubmission AXS-07 And Other Catalysts Make This A Must Watch Terry Chrisomalis • PFE
	Medifast: A Revamp Is Necessary, An Embrace Of GLP-1s Can Help Justin Purohit • PFE
	Norfolk Southern: 3M Company 2.0? Deep Value Ideas • MMM
	Stryker: Good Prospects LD Investments • JNJ
	Energy, Tech And AI: Use Cases And Markets Jennifer Warren • XOM • CVX
	RGA Investment Advisors Q1 2023 Investment Commentary Fund Letters • PG • JNJ
	My Dividend Stock Portfolio: New All-Time Dividend Record - 99 Holdings With 25 Buys Stefan Redlich • D • T • KO
	Canadian Natural Resources: One Of The Best In The Industry Jonathan Weber • XOM • CVX
	Painful Dividend Cuts: The Biggest Warning Sign I Failed To Heed Samuel Smith • T
	A Commonsense Approach To The Energy Transition VettaFi Research • XOM • CVX
	ConocoPhillips: A Solid Oil Producer Going Through A Weak Period Fun Trading • XOM • CVX
	Riding The AI Wave: Oracle's Ambitious Growth Narrative From FYQ4 Earnings Zen Analyst • IBM
	MOAT: Fortify Your Portfolio With Quality Companies Craig Blanchfield, CFA • D • PFE
	11 Buyable Inflation-Busting June Dividend Stocks Fredrik Arnold • PFE
	Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet Vince Martin • JNJ
	SCHV: Well Diversified, But Still Lagging Competitors Fred Piard • PG • JNJ • XOM
	Stock Ideas After Cooler CPI Report Chris Lau • T • KO • RTX
	Nicholas Ward's Dividend Growth Portfolio: April And May Review Nicholas Ward • KO • JNJ • BMY
	USO: Geopolitical Risk Likely To Weigh On Crude Prices The Methodical Investor • XOM
	Halliburton And Schlumberger: Solid Players In Oilfield Services Fun Trading • BKR
	Equitrans Midstream And The Most Valuable Pipeline TJ Roberts • DUK • D
	2 REITs All Investors Should Own Jussi Askola • T
	LRT Capital Management May 2023 Investor Update Fund Letters • XOM • DE
	That Predicted Interest-Rate-Induced Stock Sell-Off Last Week Didn't Happen... It's Coming David H. Lerner • MMM
	PepsiCo: Generating SPY's Gains Without The Volatility Juxtaposed Ideas • KO
	Kinnate Biopharma: Trading Below Cash Value Busted IPO Forum • JNJ
	Devon Energy: A Definite Buy Below Management Share Repurchase Prices Juxtaposed Ideas • XOM • CVX
	Dividend Champion, Contender, And Challenger Highlights: Week Of June 11 Justin Law • DUK • KO • K
	Titan International: Shares Have Gotten Cheap Enough At Last Daniel Jones • DE
	June MDA Breakout Stocks/ETFs Week 24 - 2023: High-Frequency Gainers To Give You An Edge JD Henning • IBM • CVX • DOW

Download the Seeking Alpha App!

Want More Investing Ideas Newsletters?

Get the Newest Stock Ideas → Stock Ideas

Popular ETF Ideas → ETF Ideas

Stock Ideas for Dividend Investors → Dividends Ideas

Click here to manage notifications for all your portfolios.

This email was sent to you because you signed up to receive Pre-Market Portfolio Digest. If you do not want to receive Delacrox Portfolio Digest emails, click here to unsubscribe.

Sent by Seeking Alpha, 234 5th Avenue, 5th floor, New York, NY 10001

If you believe this has been sent to you in error, please safely unsubscribe.